FreeTrader
عضو محترف
تابعو شرعيتهم لا اعلم عنها شي
ARNA
6/13/2006 8:14:50 AM Arena Pharmaceuticals (ARNA) reported results from a Phase IIb study of clinical trial of lorcaserin hydrochloride, for the treatment of obesity, after the close on Monday. The results showed that patients treated with lorcaserin experienced a highly statistically significant average weight loss and reductions in other physical measures, including body mass index and waist and hip circumference. The stock is now trading higher by 0.74 on 18K shares Tuesday morning on Inet
ARNA
6/13/2006 8:14:50 AM Arena Pharmaceuticals (ARNA) reported results from a Phase IIb study of clinical trial of lorcaserin hydrochloride, for the treatment of obesity, after the close on Monday. The results showed that patients treated with lorcaserin experienced a highly statistically significant average weight loss and reductions in other physical measures, including body mass index and waist and hip circumference. The stock is now trading higher by 0.74 on 18K shares Tuesday morning on Inet